Moda is third insurer to sue over ACA risk-corridor payments

John Gregory | | Health Exec | Economics

Portland, Ore.-based Moda Health has filed a lawsuit against the federal government for $180 million it says its owed in risk-corridor payments included in the Affordable Care Act, according to the Portland Business Journal. 

Two other insurers, Highmark and Health Republic Insurance of Oregon, had previously filed suits over HHS paying only 12.6 percent of the $2.9 billion requested by insurers to mitigate losses on ACA exchanges in the first years of open enrollment.

To read more about Moda’s lawsuit, click on the link below:

Moda sues feds to recoup $180M owed under Obamacare program

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Related Content

Walgreens confirms $10B sale to PE, as part of $24B transaction
5 ways AI can help make healthcare more affordable for everyone
More than 1,000 hospitals earn $700M opioid crisis judgment
Building a successful CCTA program: Physicians and healthcare executives to share advice
VA planning 83,000 layoffs as part of restructuring
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.